Predictive Factors for Failed Nonsurgical Management of Long Bone Metastasis and Myeloma
Open Access
- 1 February 2025
- journal article
- Published by Wolters Kluwer Health in JAAOS: Global Research and Reviews
- Vol. 9 (2)
Abstract
Background: Understanding the risk factors for failing nonsurgical management of metastatic bone disease is necessary to determine those patients who will benefit from prophylactic stabilization; however, standard predictive models do not include several clinically relevant factors. The primary and secondary objectives of this study were to evaluate comprehensive patient- and disease-related factors as potential predictors of failure of radiation therapy alone for long bone lesions and overall survival in metastatic disease and myeloma. Methods: All patients who underwent radiation therapy for long bone metastases at our tertiary care institution from May 2011 to February 2020 were retrospectively reviewed. Of 475 lesions, we excluded those with prophylactic fixation or fracture before radiation therapy, and those P = 0.025), lesion cortical involvement (OR = 16.96, P = 0.010), and younger patient age (OR = 0.93, P = 0.024). Fracture was associated with lesion cortical involvement (OR = 10.16, P = 0.003) and “low risk” histology (OR = 9.01, P = 0.057). Orthopaedic treatment (either prophylactic surgery or pathologic fracture management) was associated with Mirels' score (OR = 1.62, P = 0.015), lesion cortical involvement (OR = 8.94, P = 0.002), humerus location (OR = 4.19, P = 0.042), and Medicare (OR = 4.12, P = 0.062) or private insurance (OR = 5.69, P = 0.022) compared with Medicaid. ECOG score (OR = 1.28, P = 0.003) was found to be a risk factor for increased mortality after radiotherapy, while “low risk” histology (OR = 0.51, P = 0.029), mixed lesion type (OR = 0.34, P = 0.006), and increased body mass index (OR = 0.95, P = 0.001) were protective factors. Conclusions: Radiograph measurements of cortical involvement were the most clinically relevant for determination of metastatic lesion fracture risk; however, predictors of local failure not addressed in Mirels' score should be considered in clinical decisions about prophylactic fixation. Surgery may be underperformed for histologies commonly considered to be “low risk” for local progression after radiation therapy.Keywords
This publication has 33 references indexed in Scilit:
- Prophylactic Radiation Therapy vs. Standard-of-Care for Patients with High-Risk, Asymptomatic Bone Metastases: A Multicenter, Randomized Phase II TrialInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2022
- Fracture risk assessment and clinical decision making for patients with metastatic bone diseaseJournal of Orthopaedic Research, 2020
- Single vs. multiple fraction regimens for palliative radiotherapy treatment of multiple myelomaStrahlentherapie und Onkologie, 2017
- Risk factors for same-admission mortality after pathologic fracture secondary to metastatic cancerSupportive Care in Cancer, 2016
- Is Prophylactic Intervention More Cost-effective Than the Treatment of Pathologic Fractures in Metastatic Bone Disease?Clinical Orthopaedics and Related Research, 2016
- CT-based Structural Rigidity Analysis Is More Accurate Than Mirels Scoring for Fracture Prediction in Metastatic Femoral LesionsClinical Orthopaedics and Related Research, 2016
- Survival analysis of patients with femoral metastasesJournal of Surgical Oncology, 2011
- Metastatic bone disease: the requirement for improvement in a multidisciplinary approachInternational Orthopaedics, 2008
- The Role of External Beam Radiotherapy in the Management of Bone MetastasesClinical Oncology, 2006
- Remineralisation und Schmerzlinderung von Knochenmetastasen nach unterschiedlich fraktionierter Strahlentherapie (10mal 3 Gy vs. 1mal 8 Gy) Eine prospektive StudieStrahlentherapie und Onkologie, 1999